Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | PI4KA | P42356 | 1/20 | 0.48 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.48 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.48 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.41 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28576110 | 0.97 | GAA (0.44) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL2585614 | 0.95 | MEN1 (0.46) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL30507756 | 0.95 | MEN1 (0.46) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL21195750 | 0.93 | MEN1 (0.48) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL31109976 | 0.93 | MEN1 (0.48) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL10296294 | 0.92 | GAA (0.48) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL30507752 | 0.92 | GAA (0.48) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL14582723 | 0.92 | MEN1 (0.43) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL1696798 | 0.91 | ALDH1A1 (0.52) | MEN1KMT2AGAAPI4KAPI4K2B | |
| SCHEMBL27412107 | 0.91 | ALDH1A1 (0.49) | MEN1KMT2AGAAPI4KAPI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029055-B2 | OLED with hybrid emissive layer | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-07-02 | — | — | US | disclosed |
| US-20230225147-A1 | ORGANIC LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-11696492-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-20220173333-A1 | HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) | 2022-06-02 | — | — | US | disclosed |
| US-20190177303-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-13 | — | — | US | disclosed |
| US-10080739-B2 | Aryl imidazoles and their use as anti-cancer agents | APTOSE BIOSCIENCES INC. (CA) | 2018-09-25 | — | — | US | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-9917270-B1 | Organic electroluminescent device having an exciton quenching layer | CYNORA GMBH (DE) | 2018-03-13 | — | — | US | disclosed |
| US-9353065-B2 | Heterocyclic bridged biphenyls | BASF SE (DE) | 2016-05-31 | — | — | US | disclosed |
| US-20150374669-A1 | ARYL IMIDAZOLES AND THEIR USE AS ANTI-CANCER AGENTS | LORUS THERAPEUTICS INC. (CA) | 2015-12-31 | — | — | US | disclosed |
| US-20150137083-A1 | CONJUGATED AROMATIC DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2015-05-21 | — | — | US | disclosed |
| US-20150137083-A1 | CONJUGATED AROMATIC DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2015-05-21 | — | — | US | disclosed |
| US-8969372-B2 | Aryl imidazoles and their use as anti-cancer agents | Aptose Boisciences Inc. (CA) | 2015-03-03 | — | — | US | disclosed |
| CN-103772361-A | Organic semiconductor material containing carbazole, preparation method thereof, and organic electroluminescent device | OCEANS KING LIGHTING SCIENCE | 2014-05-07 | — | — | CN | disclosed |
| US-8628862-B2 | Electroluminescent device | BASF SE (DE) | 2014-01-14 | — | — | US | disclosed |
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-04-19 | — | — | US | disclosed |
| US-20100277060-A1 | ELECTROLUMINESCENT DEVICE | BASF SE (DE) | 2010-11-04 | — | — | US | disclosed |
| US-20100109514-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| US-20080262015-A9 | Aryl imidazoles and their use as anti-cancer agents | LORUS THERAPEUTICS INC. (CA) | 2008-10-23 | — | — | US | disclosed |
| US-20070123553-A1 | Aryl imidazoles and their use as anti-cancer agents | LORUS THERAPEUTICS INC. (CA) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123553-A1 | Aryl imidazoles and their use as anti-cancer agents | AHR, AADAC, CBR3 | MEN1 4554/4885KMT2A 396/4885GAA 4312/4885 |
| US-20100109514-A1 | HETEROCYCLIC BRIDGED BIPHENYLS | OCIAD1, SBDS, OCIAD2 | MEN1 3281/4885KMT2A 3605/4885GAA 3015/4885 |
| US-20120095222-A1 | PHENANTHRO[9, 10-B]FURANS FOR ELECTRONIC APPLICATIONS | P2RY10, P2RY11, P2RY12 | MEN1 660/4885KMT2A 3627/4885GAA 3641/4885 |
| US-20220173333-A1 | HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | KCNH1, OCIAD2, ETFB | MEN1 2438/4885KMT2A 1180/4885GAA 3510/4885 |
| US-12029055-B2 | OLED with hybrid emissive layer | S1PR4, S1PR1, S1PR2 | MEN1 94/4885KMT2A 2918/4885GAA 4871/4885 |
| US-20150374669-A1 | ARYL IMIDAZOLES AND THEIR USE AS ANTI-CANCER AGENTS | AHR, CBR3, AADAC | MEN1 4554/4885KMT2A 362/4885GAA 4420/4885 |
| US-10080739-B2 | Aryl imidazoles and their use as anti-cancer agents | AHR, CBR3, AADAC | MEN1 4554/4885KMT2A 362/4885GAA 4420/4885 |
| US-11696492-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, ODC1 | MEN1 4521/4885KMT2A 2280/4885GAA 1427/4885 |
| US-20080262015-A9 | Aryl imidazoles and their use as anti-cancer agents | AHR, AADAC, CBR3 | MEN1 4554/4885KMT2A 396/4885GAA 4312/4885 |
| US-20100277060-A1 | ELECTROLUMINESCENT DEVICE | LEF1, PIEZO1, ETV6 | MEN1 170/4885KMT2A 2793/4885GAA 1064/4885 |
| US-20190177303-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | MEN1 3148/4885KMT2A 3925/4885GAA 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.